BEIJING: China’s National Medical Products Administration (NMPA) has granted conditional market approval to CoronaVac, an inactivated Covid-19 vaccine developed by Sinovac Biotech, the company said.The Sinovac vaccine, produced by the Beijing-based Sinovac Life Sciences Co Ltd, affiliated with Sinovac Biotech, was approved for emergency use in China last June.
It started being used for emergency inoculation among special groups in China from July last year.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
